ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

The efficacy of Cognitive-Behavioral Therapy (CBT + TAU) on reducing type-I Bipolar disorder symptoms

Journal: Shenakht Journal of Psychology and Psychiatry (Vol.7, No. 2)

Publication Date:

Authors : ;

Page : 92-103

Keywords : Cognitive behavioral therapy; Drug therapy; Bipolar disorder-I;

Source : Downloadexternal Find it from : Google Scholarexternal


Introduction: Bipolar disorder is one of the most common psychiatric disorders. To treat and prevent the recurrence of the symptoms of this disorder, it is necessary to obtain information about treatment methods such as group cognitive-behavioral therapy with different techniques. Aim: The aim of this study was to evaluate the efficacy of cognitive-behavioral therapy with the drug in reducing the signs and symptoms of bipolar type -I disorder. Method: This is a pilot-experimental study (pre-test and post-test). The statistical population of this study was all patients with type-I bipolar disorder admitted to Ardabil Fatemi Hospital in 2018. In order to select the statistical sample, by using the available sampling method, 24 people from the mentioned population were selected (based on psychiatric diagnosis) and were replaced in two groups (experimental and control). SCID and Yang Mania scales were used to collect the data. Then, the data were entered into SPSS-21 software. For statistical analysis, Levn and covariance test were used. Results: The results of statistical analysis showed that cognitive-behavioral therapy with drug had a significant effect on manic indicators and reduces its symptoms in patients with this disorder (P=0.05). Conclusion: Cognitive-behavioral therapy can be used as a complementary therapeutic, along with pharmacotherapy, to reduce the signs and symptoms of type-I bipolar disorder. Also, according to the results of this study, the use of a team approach based on the cooperation of a psychologist and a psychiatrist in the treatment of mood disorders is recommended.

Last modified: 2020-08-17 14:14:04